Reaches 50% of Crowdfunding Goal

Batu Biologics Reaches 50% of Crowdfunding Goal
Lung Cancer Vaccine Company Leverages Online Donations to Fund Preclinical Research

We are enthusiastic at the flurry of support, which we attribute in part to the joining of UCSD cancer vaccine expert Dr. Boris Minev and industry veteran Dr. Alan Lewis to our scientific advisory board.

Read the full article at businesswire.com